AI Article Synopsis
- The rise in actionable molecular targets for cancer treatment has increased the need for high-quality tissue samples for next-generation sequencing (NGS), which is critical for timely patient management.
- Interventional radiologists need to familiarize themselves with NGS technologies, their applications, and essential factors that ensure successful tissue sampling and sequencing.
- The review emphasizes the importance of proper tissue collection methods and imaging, while also addressing the challenges of undersampling and potential improvements in interventional radiology practices.
Article Abstract
The discovery of increasing numbers of actionable molecular and gene targets for cancer treatment has driven the demand for tissue sampling for next-generation sequencing (NGS). Requirements for sequencing can be very specific, and inadequate sampling leads to delays in management and decision making. It is important that interventional radiologists are aware of NGS technologies and their common applications and be cognizant of the factors that contribute to successful sample sequencing. This review summarizes the fundamentals of cancer tissue collection and processing for NGS. It elaborates on sequencing technologies and their applications with the aim of providing readers with a working understanding that can enhance their clinical practice. It then describes imaging, tumor, biopsy, and sample collection factors that improve the chances of NGS success. Finally, it discusses future practice, highlighting the problem of undersampling in both clinical and research settings and the opportunities within interventional radiology to address this.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jvir.2023.03.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!